Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated analysis of IGHV rearrangements and cytogenetic abnormalities in a large chronic lymphocytic leukemia cohort (CLL-POL1).

BMC cancer·2026
Same author

Hybrid BSA-PEO nanofibers as a stable biointerface for electrochemical cortisol immunosensing.

Colloids and surfaces. B, Biointerfaces·2026
Same author

Systemic toxicity and immunotoxicity studies of glucose oxidase-loaded extracellular vesicles derived from lung cancer cells.

Frontiers in immunology·2026
Same author

Cross-linking of collagen fibrils leads to preferential gap zone mineralization in vitro.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Quizartinib for patients with newly diagnosed FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First.

Blood advances·2026
Same author

Translating magnetic fluid hyperthermia toward lung cancer treatment.

Nanoscale·2026

Related Experiment Video

Updated: May 26, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.1K

Diagnostic Approaches in Myeloid Sarcoma.

Elzbieta Patkowska1, Agnieszka Krzywdzinska2, Iwona Solarska3

  • 1Department of Haematopoietic Stem Cell Transplantation, Institute of Hematology and Transfusion Medicine, 02-776 Warsaw, Poland.

Current Issues in Molecular Biology
|February 25, 2025
PubMed
Summary

Myeloid sarcoma (MS), a rare tumor outside the bone marrow, presents diagnostic challenges. Comprehensive diagnostics and novel therapies are crucial for improving outcomes in this challenging hematologic neoplasm.

Keywords:
acute myeloid leukaemiadiagnostic approachesmyeloid sarcoma

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.5K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.1K

Related Experiment Videos

Last Updated: May 26, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.1K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.5K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.1K

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Myeloid sarcoma (MS), also known as extramedullary acute myeloid leukemia tumor (eAML), is a rare hematopoietic neoplasm.
  • It is recognized as a distinct entity within acute myeloid leukemia (AML), posing diagnostic challenges due to its rarity, heterogeneity, and variable characteristics.
  • The mechanisms of leukemic stem cell migration to extramedullary sites remain unclear, with MS occurring de novo, preceding AML, or during relapse, and associated with myelodysplastic syndromes (MDSs) or myeloproliferative neoplasms (MPNs).

Purpose of the Study:

  • To review the diagnostic challenges and therapeutic approaches for myeloid sarcoma.
  • To highlight the need for comprehensive diagnostic methods for better risk stratification and treatment selection.
  • To explore the role of novel targeted therapies and emphasize the need for multicenter data collection.

Main Methods:

  • Review of existing literature on myeloid sarcoma.
  • Discussion of diagnostic modalities including tissue biopsy, bone marrow evaluation, and advanced imaging.
  • Exploration of prognostic factors and emerging therapeutic strategies.

Main Results:

  • MS commonly affects organs like skin, lymph nodes, GI tract, and CNS, leading to diverse clinical presentations.
  • Accurate diagnosis is critical for risk stratification and treatment selection.
  • Prognosis is influenced by anatomical location, timing of diagnosis, genetic profile, and treatment.

Conclusions:

  • Comprehensive diagnostic approaches are essential for characterizing MS and determining prognosis.
  • Novel targeted therapies show promise for improving patient outcomes.
  • Future multicenter data collection is critical for optimizing diagnostic and therapeutic strategies for myeloid sarcoma.